Skip to main content

Advertisement

SpringerLink
Log in

Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

The purpose of medical treatment in the caustic esophageal burns (CEB) is to decrease inflammatory reaction and to prevent stricture formation. Resveratrol has anti-inflammatory and antifibrotic properties. The aim of this study is to investigate potential therapeutic effects of resveratrol in experimental CEB. We divided 42 male Wistar albino rats into five groups: a control group, caustic groups 4 and 28 (esophageal burns were created), and resveratrol groups 4 and 28 (esophageal burns were created and resveratrol was administered). We used 25% NaOH to form CEB following the method of Gehanno and Guedon as modified by Liu and Richardson. Animals were killed on the 4th and 28th days for biochemical and histopathological examinations. We found that the mean malondialdehyde and nitric oxide assays of the caustic groups were significantly higher than that of the resveratrol groups (P < 0.05). On the other hand, glutathione assay of the resveratrol groups was significantly higher than that of the caustic groups (P < 0.05). Histologically, edema, inflammation and necrosis were found to be significantly lower in the resveratrol 4 group compared with the caustic 4 group (P < 0.05). Submucosal and muscular collagen accumulation were found significantly lower in the resveratrol 28 group compared with the caustic 28 group (P < 0.05). We conclude that resveratrol decreased both the inflammatory reaction and the stricture formation in experimental CEB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wasserman RL, Ginsburg CM (1985) Caustic substance injuries. J Pediatr 107:169–174

    Article  PubMed  CAS  Google Scholar 

  2. Karnak I, Tanyel FC, Buyukpamukcu N, Hicsonmez A (1999) Combined use of steroid, antibiotics and early bougienage against stricture formation following caustic esophageal burns. J Cardiovasc Surg (Torino) 40:307–310

    CAS  Google Scholar 

  3. Günel E, Çağlayan F, Çağlayan O, Canbilen A, Tosun M (2002) Effect of antioxidant therapy on collagen synthesis in corrosive esophageal burns. Pediatr Surg Int 18:24–27

    Article  PubMed  Google Scholar 

  4. Arbell D, Udassin R, Koplewitz BZ, Ohana M, Genina O, Pines M, Nagler A (2005) Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis. Laryngoscope 115:1632–1635

    Article  PubMed  Google Scholar 

  5. Temir ZG, Karkıner A, Karaca I, Ortaç R, Ozdamar A (2005) The effectiveness of sucralfate against stricture formation in experimental corrosive esophageal burns. Surg Today 35:617–622

    Article  PubMed  CAS  Google Scholar 

  6. Yeming W, Somme S, Chenren S, Huiming J, Ming Z, Liu DC (2002) Balloon catheter dilatation in children with congenital and acquired esophageal anomalies. J Pediatr Surg 37:398–402

    Article  PubMed  Google Scholar 

  7. Günel E, Çağlayan F, Çağlayan O, Akıllıoğlu I (1999) Reactive oxygen radical levels in caustic esophageal burns. J Pediatr Surg 34:405–407

    Article  PubMed  Google Scholar 

  8. Fremont L (2000) Biological effects of resveratrol. Life Sci 66:663–673

    Article  PubMed  CAS  Google Scholar 

  9. Johnson JL, Maddipati KR (1998) Paradoxal effects of resveratrol on the two prostaglandin H synthases. Prostaglandins 56:131–143

    CAS  Google Scholar 

  10. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220

    Article  PubMed  CAS  Google Scholar 

  11. Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG (2005) Inhibition of cardiac fibroblast proliferation and myofibroblast differention by resveratrol. Am J Physiol Heart Circ Physiol 288:H1131–H1138

    Article  PubMed  CAS  Google Scholar 

  12. Moreno JJ (2000) Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 294:333–338

    PubMed  CAS  Google Scholar 

  13. Chavez E, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P (2008) Resveratrol prevents fibrosis, NF- kappa B activation and TGF- beta increases induced by chronic CCI (4) treatment in rats. J Appl Toxicol 28:35–43

    Article  PubMed  CAS  Google Scholar 

  14. Gehanno G, Guedon C (1981) Inhibition of experimental esophageallye strictures by penicillamine. Arch Otolaryngol 107:145–147

    PubMed  CAS  Google Scholar 

  15. Liu AJ, Richardson AM (1985) Effects of N-Acetylcysteine on experimentally induced esophageal lye injury. Ann Rhinol Laryngol 94:477–481

    CAS  Google Scholar 

  16. Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271–278

    Article  PubMed  CAS  Google Scholar 

  17. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277–279

    Article  PubMed  CAS  Google Scholar 

  18. Wennmalm A, Benthin G, Peterson AS (1992) Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell hemoglobin. Br J Pharmacol 106:507–518

    PubMed  CAS  Google Scholar 

  19. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443

    PubMed  CAS  Google Scholar 

  20. Millar AJW, Cywes S (1998) Caustic strictures of the esophagus. In: O’Neill JA, Rowe MI, Grosfeld JL (eds) Pediatric surgery. Mosby Year Book Inc, St Louis, pp 970

    Google Scholar 

  21. Van der Vliet A, Bast A (1992). Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med 12:499–513

    Article  PubMed  Google Scholar 

  22. Villa P, Soccani A, Sico A, Ghezzi P (2002) Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defence. JID 185:1115–1120

    Article  PubMed  CAS  Google Scholar 

  23. Bekyarova G, Yankova T (1998) Alpha-Tocopherol and reduced glutathione deficiency and decreased deformability of erythrocytes after thermal skin injury. Acta Physiol Pharmacol Bulg 23:55–59

    PubMed  CAS  Google Scholar 

  24. Sekhar KR, Spitz DR, Haris S, Nguyen TT, Meredith MJ, Holt JT, Gius D, Marnett LJ, Summer ML, Freeman ML, Guis D (2002) Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression og gamma-glutamylcysteine synthetase. Free Radic Biol Med 32:650–662

    Article  PubMed  CAS  Google Scholar 

  25. Kim SM, Byun JS, Jung YD, Kang IC, Choi SY, Lee KY (1998) The effects of oxygen radicals on the activity of nitric oxide synthase and guanylate cyclase. Exp Mol Med 30:221–226

    PubMed  CAS  Google Scholar 

  26. Leiro J, Alvarez E, Garcia D, Orallo F (2002) Resveratrol modulates rat macrophage functions. Int Immunopharmacol 2:767–774

    PubMed  CAS  Google Scholar 

  27. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431

    Article  PubMed  CAS  Google Scholar 

  28. Godichaud S, Krisa S, Couronne B, Dubuisson L, Merillon JM, Desmouliere A, Rosenbaum J (2000) Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 31:922–931

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We thank Fisun Hamaratoglu (MDACC, Houston, TX, USA) for critical reading of the manuscript.

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Pediatric Surgery, Turgut Ozal Medical Center, Inonu University, 44069, Malatya, Turkey

    S. Uguralp, C. Irsi & T. Aksoy

  2. Department of Biochemistry, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey

    A. Bay Karabulut

  3. Department of Pathology, Turgut Ozal Medical Center, Inonu University, Malatya, Turkey

    H. Kirimlioglu & B. Mizrak

Authors
  1. S. Uguralp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Irsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Aksoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Bay Karabulut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Kirimlioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Mizrak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Uguralp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uguralp, S., Irsi, C., Aksoy, T. et al. Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns. Pediatr Surg Int 24, 425–430 (2008). https://doi.org/10.1007/s00383-008-2116-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-008-2116-x

Keywords

Search

Navigation